Home › Heart Valve Diseases › NCT03826264
Transpacific TAVR Registry
RecruitingObservational study
a Multinational Multicenter Prospective Transpacific TAVR Registry
Who can join
Ages 19 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All patients undergoing TAVR * Informed consent
About the study
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
What is being tested
- TAVR (procedure)
Sponsor: Duk-Woo Park, MD · Participants: 10,000 · Started: Jun 15, 2019
Contact the study team
- Duk-woo Park, MD · Phone: 82230103995
Official record on ClinicalTrials.gov — NCT03826264
Locations in the U.S.
| California | Stanford University, Stanford |
| Illinois | Northwestern Memorial Hospital, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.